From the staurosporine producing strain R-19 Streptomyces longisporoflavus various minor metabolites were isolated: They include new compoundswith a keto function at carbon 4' of staurosporine and several metabolites related to TAN-1030A. The new structures were elucidated by spectroscopic methods, mainly XH NMRand 13C NMRand by comparison with TAN-1030A. The new compounds inhibited protein kinase C with IC50 values in the micromolar range with the exception of those compoundsthat are alkylated at the lactam nitrogen.
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The family of protein kinase C (PKC) subtypes plays a key role in signal transduction and cellular regulation1>. A variety of tumor promoting phorbol esters are able to bind to and activate PKC2), suggesting that inhibitors of that enzyme are potentially useful as anticancer drugs.
Staurosporine, isolated from Streptomyces staurosporeus as an alkaloidal antibiotic3), was found to be the first compound that inhibited PKCin the low nanomolar range4). The absolute stereochemistry of staurosporine was determined only very recently5). Staurosporine binds not only to the ATP binding-site of various protein kinases but also blocks the autophosphorylation of neurotrophin receptors6) and might interact with other ATP-dependent proteins. Staurosporine derivatives have attracted further interest, because they have been found to reverse multidrug resistance7), presumably by direct interaction with the P-glycoprotein8). A semisynthetic derivative of staurosporine that showsa high degree of selectivity for PKCexerted strong antitumor activities in several animal models9). More simple synthetic analogues related to the aglycone of staurosporine are actively pursued by others10).
In a previous publication we described several metabolites produced by Streptomyces longisporoflavus strain R-19 , including a nitro analogue of staurosporine, that were isolated in course of the preparation of larger quantities ofstaurosporine1 x\ In the present communication the production, isolation, physico-chemical data, 519 structure elucidation and biological properties of further minor metabolites are described.
Results
Fermentation and Isolation A 2000-liter fermentation and the isolation of the crude extract were performed as described earlier11}. Silica gel chromatography yielded three fractions: an unpolar one, one containing staurosporine and a polar one containing mainly basic compounds1 1}. The purification procedure is described in the Experimental part and summarizedin Schemes 1 and 2.
Structure Elucidation
The absolute stereochemistry at centers 2' and 6'tf of compounds2, 8 and 9 was shownto be the same as in TAN-1030A (1)12) by measurement of CD spectra in ethanol and comparison with 1.
7-Hydroxy Derivative of TAN-1030A (2)
The elementary composition was determined to be C27H22N4O5 by HRFAB-MSindicating one additional oxygen atom compared to TAN-1030A.Analysis of *H NMR (Table 1) and 13C NMR(Table 2 ) and comparison to those of TAN-1030A (1)12) and UCN-01 (3)13) leads to structure 2 in a straight-forward way. CD-Spectra of 1, 2, 3 and staurosporine were recorded in an unsucf Postdoctoral fellow 1989-1992. Current Address: Beijing Medical University, Bdg. 24-4-14, Beijing 100083, P.R. China. n Three different nomenclatures for staurosporine type alkaloids are used in the literature. Wewill use the numbering system for staurosporine assigning position V to the oxygen, since this metabolite has been described first and has been investigated most extensively. cessful attempt to define the stereochemistry at C-7 (see Experimental part). This compound was identified in comparison to semisynthetic material obtained from staurosporine14). The CDspectrum of 3 is included for reference purposes.
7-Oxo-derivative of TAN-1030A (4) This compound shows the typical yellow fluorescence on TLCplates of 7-oxo-derivatives of the staurosporine chromophore. The elementary composition was determined to be C27H20N4O5 by HREI-MS demonstrating the presence of one additional oxygen and the lack of two hydrogens compared to TAN-1 030A. Comparison of the XHNMRspectral data with 1 disclosed the absence of the H-7 methylene protons. The presence ofa carbonyl group at C-7 was indicated by a second deshielded aromatic proton at 9.08ppm. The 13C NMRdata were compared to those of 1 and 7-oxo-staurosporine14) and proved structure 4 to be correct. Assignments with asterisks may be interchanged. Solvent: DMSO-<i6,temperature ambient.
6 and a methoxy group instead of the 2-propan-2-yl group in 6.
6-Alkylated Derivative of K-252c (7) EI-MS reveals a molecular weight of 383. In the *H NMRof 7 in DMSO-J6 all signal of the aglycone of staurosporine, K-252c15), were clearly observed with the exception of the lactam proton of nitrogen 6, suggesting a substitution at that position. In addition a (CH3)2CH-O and a singlet CH2 at 5.14 were observed. These structural elements can be only combined as shown in, structure 7. The 13C NMRdata are well compatible with the proposed structure and the closely related compound 6. As expected the signals of the carbons 4c, 5 and 7 and 7a are shifted by more than 2ppm in comparison to K-252c or TAN-1030A (1).
4/-Oxo Derivatives 8 and 9
The XHNMRdata of both compounds (Table 1) showed a striking resemblance to TAN-1030A (1) Table 2 ). The 13C NMR spectra of the two compoundsare quite similar although differences are observed for the 2/-methyl group and for carbons 3' to 5' of about 4ppm suggesting epimeric compounds.NOEdifference experiments in acetone-d6 clarify that the two compoundshave to be epimeric at center 3': only in compound8 irradiation of the axial proton 5' gave rise to a NOEof 13% on 3 -H indicating that both protons are in an axial position.
Thus the methoxy group has to be in an equatorial position leading to structure 8 and consequently to structure 9. Irradiation on the 2/-methyl group provides additional evidence by causing a considerably more pronounced NOEon proton 3' in compound 8 (13%) than in 9 (3%). The observed long range effects in the 13C NMRare in agreement with the suggested structures.
Biological Properties All compounds tested inhibit porcine PKC9) in the nanomolar to micromolar range ( Table 3 ). The com-523 pounds with a 4/-oxime or ketone function inhibit the protein kinases in a similar range like the knownmetabolite TAN-1030A, with the exception of compound 6 which is alkylated at the 7-nitrogen. A dramatic loss of activity upon substitution of that position has been shown before in the staurosporine series14). Therefore the PKC-inhibitory activity of the compounds 5 and 7 was not investigated. Most compounds are less active against PKC than staurosporine and are effective inhibitors of phosphorylase kinase.
Discussion
Compound 2 seems to be an oxidation product of TAN-1030A,just in the way UCN-01 (3) is a hydroxylated product of staurosporine. As both compounds were isolated as minor metabolites, it seems that the hydroxylating enzyme cannot discriminate between TAN1030Aand staurosporine. Further oxidation of 1 or 2 either during the fermentation or during workup leads to the yellow compound 4 with an imide function.
Structure 4 is related to 7-oxo-staurosporine, which was found as an inhibitor of PKCproduced by Streptomyces platensis16). It can not be excluded that the 6-alkylated compounds 5, 6, and 7 are formed during workup, since methanol and 2-propanol have been used in the isolation procedure. It seems however, that at least the carbon 1"
which is a formaldehyde equivalent could be attached during the fermentation. In our present and earlier work11} we have isolated several compoundswhich are formic acid derivatives or which, like compounds 5 to 7, contain equivalents of formaldehyde and it can be speculated that such compoundsmight have a specific role: formylation at the 6-or at the 4'-nitrogen leads to metabolites which are muchless toxic, as they inhibit many protein kinases at much higher IC50-values (Table  3) 11}. They might protect the microorganism against its own metabolite, since staurosporine itself is toxic to the producing organism1 7). After completion of the biosynthesis formylated staurosporine might be transported to the outside of the cell and bound to the mycelium. Further protection would no longer be required and the formyl moieties could be cleaved off. Compound9 is epimeric to compound8 at the center 3' which is slightly acidic, being a to the 4'-ketone function. Whether compound 9 is genuinely produced by the microorganismor formed as an artefact is not completely clear, but we have not found any evidence for an epimerization of 3' under isolation conditions.
Whenthe fermentation of S. longisporoflavus was monitored by HPLC, a very small peak with the retention time of 9 was observed.
Experime ntal
The following instruments were used in this study: CEC-121 B, VG 70-4SE (for HREI-MS) mass spectrometers, Varian VXR-400S NMRspectrometer, Perkin Elmer Lamda 5 UV/VIS spectrophotometer, Perkin Elmer 241 polarimeter and Perkin Elmer 983G IR spectrophotometer.
General remarks: Melting points are uncorrected.
Large scale liquid chromatography on silica gel was done using a mediumpressure system equipped with a Buchi Aliquots of such material (850 g in total) were separated into three fractions by silica gel chromatography (3 liters; 4 runs). The nonpolar fraction 1 was eluted with CH2C12 -2-PrOH-AcOH, 95 :4 : 1, (8 liters) giving 365g of a brown oil. Fraction 2 contained staurosporine and was eluted first with CH2C12-2-PrOH, 96 :4, (4 liters) and then with CH2C12-2-PrOH-triethylamine, 96 : 4: 0.1, (6 liters).
The polar fraction 3 was eluted with CH2C12 -2-PrOH-triethylamine, 90 : 10 : 0.1, (4 liters) to
give 76 g ofa brown solid after solvent removal. Fraction 2 (383g) was triturated in CH2C12-MeOH, 10:2, 
